INTERNATIONAL PATENT: FATE THERAPEUTICS, INC. FILES APPLICATION FOR "IPSC-DERIVED EFFECTOR CELLS FOR AUTOIMMUNE DISEASE TREATMENT"

GENEVA, March 19 -- FATE THERAPEUTICS, INC. (12278 Scripps Summit DriveSan Diego, CA 92131) filed a patent application (PCT/US2024/045702) for "IPSC-DERIVED EFFECTOR CELLS FOR AUTOIMMUNE DISEASE TREATMENT" on Sep 06, 2024. With publication no. WO/2025/054537, the details related to the patent application was published on Mar 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VALAMEHR, Bahram (12278 Scripps Summit DriveSan Diego, CA 92131)

Abstract: Provided are methods and compositions for use in immunotherapies. In various embodiments, the compositions include functionally enhanced deri...